• Placebo-Controlled Evidence for Mianserin HCl in Depression

  2026-05-21

  A rigorous double-blind, placebo-controlled trial established the antidepressant efficacy of Mianserin Hydrochloride in hospitalized women with severe depression. The study highlights significant improvements in both mood and sleep quality, supporting Mianserin HCl's role as a 5-HT2 receptor antagonist in psychiatric research.

• 5-HT3 Antagonists Inhibit Renal OCT2 and MATE1: Insights for

  2026-05-21

  George et al. systematically evaluated how five clinically relevant 5-HT3 receptor antagonists inhibit renal drug transporters OCT2 and MATE1 using in vitro kidney cell models. Their findings clarify the variable inhibitory potency among these agents, revealing implications for drug interaction research and transporter-targeted experimental workflows.

• Vacuolin-1: A Precision Lysosomal Exocytosis Inhibitor for C

  2026-05-20

  Vacuolin-1 empowers membrane trafficking and plasma membrane repair research with unparalleled selectivity for lysosomal exocytosis inhibition. This guide details optimized protocols, data-driven troubleshooting, and advanced use-cases that leverage Vacuolin-1's unique properties for robust and reproducible cellular assays.

• Escitalopram Applications in Antidepressant Research Workflo

  2026-05-20

  Discover how Escitalopram from APExBIO enables high-fidelity antidepressant and anxiolytic activity assays with unmatched selectivity for serotonergic signaling. This guide delivers workflow blueprints, troubleshooting insights, and practical optimizations for reliable, reproducible results.

• Chicken ANP32A Redundancy Governs Avian Influenza Polymerase

  2026-05-19

  This study reveals that chicken ANP32A supports avian influenza polymerase through three partially redundant mechanisms: a SUMO-interacting motif, specific SUMOylation sites, and a unique avian-specific insertion. The findings clarify the species barrier at the molecular level and suggest new directions for host adaptation research.

• Perospirone (SM-9018 Freebase): Advanced Use in Schizophreni

  2026-05-19

  Perospirone (SM-9018 freebase) enables researchers to dissect serotonergic, dopaminergic, and vascular pathways in schizophrenia and cardiovascular models with precision. Its proven dual action—classic receptor antagonism and selective Kv1.5 channel inhibition—offers an experimental edge for both neuropsychiatric and vascular pharmacology studies.

• Lamotrigine: High-Purity Sodium Channel Blocker for CNS Rese

  2026-05-18

  Lamotrigine, chemically 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, is a rigorously characterized anticonvulsant compound used in neurological and cardiac research. It acts as a sodium channel blocker and serotonin pathway inhibitor, with well-documented IC50 values and exceptional purity. This article details its mechanistic rationale, validated benchmarks, and integration in state-of-the-art blood-brain barrier models.

• CUDC-907: Practical Guidance for Dual PI3K and HDAC Inhibiti

  2026-05-18

  CUDC-907 addresses the need for precise, dual inhibition of PI3K and HDAC pathways in cancer cell research, particularly in studies requiring simultaneous modulation of PI3K/AKT signaling and histone acetylation. This compound is designed specifically for controlled in vitro workflows, not for diagnostic or medical uses.

• Magnetic Stimulation Modulates GABAA ε Subunit in Schizophre

  2026-05-17

  This study demonstrates that targeted magnetic stimulation of the prelimbic cortex downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits in mouse models. The findings clarify the neural mechanisms of noninvasive brain stimulation and identify Gabre as a promising molecular target for future schizophrenia research.

• Escitalopram: Optimizing Antidepressant Research Workflows

  2026-05-16

  Escitalopram stands out as a highly selective serotonin reuptake inhibitor, enabling precision in antidepressant and anxiolytic activity studies. Learn how to leverage APExBIO's Escitalopram for robust, reproducible serotonergic pathway research—and avoid common pitfalls with expert troubleshooting tips.

• Magnetic Stimulation Downregulates GABAA ε in Schizophrenia

  2026-05-15

  This study demonstrates that targeted magnetic stimulation of the left prelimbic cortex selectively downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits in murine models. The findings define a mechanistic pathway for neuromodulation-based intervention and highlight molecular targets for advanced schizophrenia research.

• Deep Learning Enhances Cardiotoxicity Detection in iPSC-CMs

  2026-05-15

  Grafton et al. demonstrate a scalable deep learning workflow for early detection of drug-induced cardiotoxicity using iPSC-derived cardiomyocytes and high-content screening. This approach increases assay sensitivity and supports safer drug development by identifying cardiotoxic liabilities earlier in the discovery pipeline.

• Biotin-tyramide: Precision Signal Amplification for IHC & IS

  2026-05-14

  Biotin-tyramide is an advanced biotinylation reagent that enables ultrasensitive, enzyme-mediated signal amplification in immunohistochemistry (IHC) and in situ hybridization (ISH). Its mechanism leverages horseradish peroxidase (HRP) catalysis for spatially precise protein labeling. The reagent delivers high specificity and is validated for use in proximity labeling and spatial transcriptomics.

• Targeted Delivery of Amikacin into Granulomas via Dendritic

  2026-05-14

  Montes-Worboys et al. demonstrate a targeted approach for delivering amikacin into granulomas formed during Mycobacterium avium infection by using monocyte-derived dendritic cells as cellular vehicles. This strategy achieves high local antibiotic concentrations with minimal systemic exposure, offering a promising adjunct to current therapies and addressing key challenges in the treatment of nontuberculous mycobacterial infections.

• Azathramycin A: Structural Insights and Biophysical Decision

  2026-05-13

  Explore the scientific foundation of Azathramycin A as a macrolide antibiotic, with an emphasis on structural-functional insights and biophysical screening considerations for tuberculosis research. This article uniquely connects chemical stability, degradation pathways, and optimal experimental design.

15716 records 2/1048 page Previous Next 12345 下5页 Last page